Barinthus Biotherapeutics plc (BRNS) Tops Q3 EPS by 4c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q3 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• Lutnick Says 'we Trust Anthropic' - Axios
• Increasing unusual put volume: A ARRY DBX JXN BAM FIGR XRX ALT STNE FAST CG PAGP
• Hewlett Packard Enterprise (HPE) call put ratio 2.1 calls to 1 put into quarter results